16:00 | WS09 Characterization Of Hepatic Mass Lesions On Cross Sectional Imaging: A Case-based Review
Faeze Salahshour

08:30 | LI-RADS Treatment Response: How To Report HCC Viability After Locoregional Therapies (Ablation/TACE).
Faeze Salahshour

08:50 | Borderline Lesions In The Cirrhotic Liver: Imaging The Stepwise Carcinogenesis. Distinguishing Regenerative Nodules Vs. Dysplastic Nodules Vs. Early HCC.
Pooneh Dehghan

09:15 | Intrahepatic Cholangiocarcinoma: Differentiating Mass-forming CCA From HCC And Mixed HCC-CCA, Staging Pearls
Niloofar Ayoubi Yazdi

09:40 | Liver Metastases: Assessing "treatment Response" Post-chemotherapy And The Concept Of Pseudocirrhosis
Mohammad Reza Ayoubpour

10:00 | Interventional Management Of Hepatic Metastases: A Guide For Patient Selection And Interventional Procedure
Alireza Rasekhi

10:20 | Q&A

14:00 | Pancreatic Ductal Adenocarcinoma: NCCN Guidelines For Resectability
Atousa Adibi Sedeh

14:20 | Autoimmune & Groove Pancreatitis: Imaging Features To Prevent Unnecessary Surgeries
Faeze Salahshour

14:40 | Interventional Radiology In Pancreatic Pathologies: Role Of IR In Pancreatitis-related Complications And Pancreatic Carcinomas
Tayeb Hosseini

15:00 | Panel : Panel Discussion: "The Cystic Pancreas", “pancreatic Tumoral Lesions And Mimics” (interactive Panel) • Reviewing IPMNs, MCNs, And Serous Cystadenomas. When To Surveil And When To Operate. • Reviewing Pancreatic Tumors And Tumoral-appearing Lesions
Moderators : Amir Reza Radmard
Panel Members : Atousa Adibi Sedeh , Faeze Salahshour , Omid Teymouri